| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected and Quantified |
|---|
| Creation Date | 2005-11-16 15:48:42 UTC |
|---|
| Update Date | 2025-05-29 19:32:56 UTC |
|---|
| HMDB ID | HMDB0000167 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | L-Threonine |
|---|
| Description | Threonine (Thr) or L-threonine is an alpha-amino acid. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon). Amino acids are organic compounds that contain amino (-NH2) and carboxyl (-COOH) functional groups, along with a side chain (R group) specific to each amino acid. L-threonine is one of 20 proteinogenic amino acids, i.e., the amino acids used in the biosynthesis of proteins. Threonine is found in all organisms ranging from bacteria to plants to animals. It is classified as a polar, uncharged (at physiological pH), aliphatic amino acid. Threonine is sometimes considered as a branched chain amino acid. Threonine was actually the last of the 20 amino acids to be discovered (in 1938). It was named threonine because it was similar in structure to threonic acid, a four-carbon monosaccharide. Threonine is an essential amino acid in humans, meaning the body cannot synthesize it and that it must be obtained from the diet. Foods high in threonine include cottage cheese, poultry, fish, meat, lentils, black turtle bean and sesame seeds. Adult humans require about 20 mg/kg body weight/day. In plants and microorganisms, threonine is synthesized from aspartic acid via alpha-aspartyl-semialdehyde and homoserine. In proteins, the threonine residue is susceptible to numerous posttranslational modifications. The hydroxyl side-chain can undergo O-linked glycosylation and phosphorylation through the action of a threonine kinase. Threonine is abundant in human plasma, particularly in newborns. Severe deficiency of threonine causes neurological dysfunction and lameness in experimental animals. Threonine is an immunostimulant which promotes the growth of thymus gland. It also can probably promote cell immune defense function. The threonine content of most of the infant formulas currently on the market is approximately 20% higher than the threonine concentration in human milk. Due to this high threonine content the plasma threonine concentrations are up to twice as high in premature infants fed these formulas than in infants fed human milk. The whey proteins which are used for infant formulas are sweet whey proteins. Sweet whey results from cheese production. Increasing the threonine plasma concentrations leads to accumulation of threonine and glycine in the brain. Such accumulation affects the neurotransmitter balance which may have consequences for the brain development during early postnatal life. Thus, excessive threonine intake during infant feeding should be avoided. (PMID 9853925 ). Threonine is metabolized in at least two ways. In many animals it is converted to pyruvate via threonine dehydrogenase. An intermediate in this pathway can undergo thiolysis with CoA to produce acetyl-CoA and glycine. In humans the gene for threonine dehydrogenase is an inactive pseudogene, so threonine is converted to alpha-ketobutyrate. |
|---|
| Structure | InChI=1S/C4H9NO3/c1-2(6)3(5)4(7)8/h2-3,6H,5H2,1H3,(H,7,8)/t2-,3+/m1/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| (2S)-Threonine | ChEBI | | (2S,3R)-(-)-Threonine | ChEBI | | (2S,3R)-2-Amino-3-hydroxybutanoic acid | ChEBI | | 2-Amino-3-hydroxybutyric acid | ChEBI | | L-(-)-Threonine | ChEBI | | L-2-Amino-3-hydroxybutyric acid | ChEBI | | L-alpha-Amino-beta-hydroxybutyric acid | ChEBI | | L-Threonin | ChEBI | | T | ChEBI | | Thr | ChEBI | | THREONINE | ChEBI | | (2S,3R)-2-Amino-3-hydroxybutanoate | Generator | | 2-Amino-3-hydroxybutyrate | Generator | | L-2-Amino-3-hydroxybutyrate | Generator | | L-a-Amino-b-hydroxybutyrate | Generator | | L-a-Amino-b-hydroxybutyric acid | Generator | | L-alpha-Amino-beta-hydroxybutyrate | Generator | | L-Α-amino-β-hydroxybutyrate | Generator | | L-Α-amino-β-hydroxybutyric acid | Generator | | (2S,3R)-2-Amino-3-hydroxybutyrate | HMDB | | (2S,3R)-2-Amino-3-hydroxybutyric acid | HMDB | | (R-(R*,s*))-2-amino-3-hydroxybutanoate | HMDB | | (R-(R*,s*))-2-amino-3-hydroxybutanoic acid | HMDB | | (S)-Threonine | HMDB | | 2-Amino-3-hydroxybutanoate | HMDB | | 2-Amino-3-hydroxybutanoic acid | HMDB | | Threonin | HMDB | | [R-(R*,s*)]-2-amino-3-hydroxy-butanoate | HMDB | | [R-(R*,s*)]-2-amino-3-hydroxy-butanoic acid | HMDB | | [R-(R*,s*)]-2-amino-3-hydroxybutanoate | HMDB | | [R-(R*,s*)]-2-amino-3-hydroxybutanoic acid | HMDB | | L Threonine | HMDB |
|
|---|
| Chemical Formula | C4H9NO3 |
|---|
| Average Molecular Weight | 119.1192 |
|---|
| Monoisotopic Molecular Weight | 119.058243159 |
|---|
| IUPAC Name | (2S,3R)-2-amino-3-hydroxybutanoic acid |
|---|
| Traditional Name | L-threonine |
|---|
| CAS Registry Number | 72-19-5 |
|---|
| SMILES | C[C@@H](O)[C@H](N)C(O)=O |
|---|
| InChI Identifier | InChI=1S/C4H9NO3/c1-2(6)3(5)4(7)8/h2-3,6H,5H2,1H3,(H,7,8)/t2-,3+/m1/s1 |
|---|
| InChI Key | AYFVYJQAPQTCCC-GBXIJSLDSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as l-alpha-amino acids. These are alpha amino acids which have the L-configuration of the alpha-carbon atom. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic acids and derivatives |
|---|
| Class | Carboxylic acids and derivatives |
|---|
| Sub Class | Amino acids, peptides, and analogues |
|---|
| Direct Parent | L-alpha-amino acids |
|---|
| Alternative Parents | |
|---|
| Substituents | - L-alpha-amino acid
- Beta-hydroxy acid
- Short-chain hydroxy acid
- Hydroxy acid
- Fatty acid
- Amino acid
- Secondary alcohol
- Carboxylic acid
- Monocarboxylic acid or derivatives
- Alcohol
- Hydrocarbon derivative
- Primary amine
- Organooxygen compound
- Organonitrogen compound
- Organic oxide
- Primary aliphatic amine
- Organopnictogen compound
- Organic oxygen compound
- Carbonyl group
- Organic nitrogen compound
- Amine
- Aliphatic acyclic compound
|
|---|
| Molecular Framework | Aliphatic acyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Not Available | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | 256 °C | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 97 mg/mL | Not Available | | LogP | -2.94 | HANSCH,C ET AL. (1995) |
|
|---|
| Experimental Chromatographic Properties | Experimental Collision Cross Sections |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 1.06 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 9.3787 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 8.01 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 405.4 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 493.7 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 353.3 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 39.3 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 223.1 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 85.5 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 292.2 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 227.8 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 827.7 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 593.1 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 39.5 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 644.5 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 208.5 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 330.0 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 695.0 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 524.7 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 412.5 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| L-Threonine,1TMS,isomer #1 | C[C@@H](O[Si](C)(C)C)[C@H](N)C(=O)O | 1245.8 | Semi standard non polar | 33892256 | | L-Threonine,1TMS,isomer #2 | C[C@@H](O)[C@H](N)C(=O)O[Si](C)(C)C | 1169.6 | Semi standard non polar | 33892256 | | L-Threonine,1TMS,isomer #3 | C[C@@H](O)[C@H](N[Si](C)(C)C)C(=O)O | 1269.5 | Semi standard non polar | 33892256 | | L-Threonine,2TMS,isomer #1 | C[C@@H](O[Si](C)(C)C)[C@H](N)C(=O)O[Si](C)(C)C | 1281.3 | Semi standard non polar | 33892256 | | L-Threonine,2TMS,isomer #2 | C[C@@H](O[Si](C)(C)C)[C@H](N[Si](C)(C)C)C(=O)O | 1344.5 | Semi standard non polar | 33892256 | | L-Threonine,2TMS,isomer #3 | C[C@@H](O)[C@H](N[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1295.4 | Semi standard non polar | 33892256 | | L-Threonine,2TMS,isomer #4 | C[C@@H](O)[C@@H](C(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 1462.8 | Semi standard non polar | 33892256 | | L-Threonine,3TMS,isomer #1 | C[C@@H](O[Si](C)(C)C)[C@H](N[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1409.5 | Semi standard non polar | 33892256 | | L-Threonine,3TMS,isomer #1 | C[C@@H](O[Si](C)(C)C)[C@H](N[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1396.4 | Standard non polar | 33892256 | | L-Threonine,3TMS,isomer #1 | C[C@@H](O[Si](C)(C)C)[C@H](N[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1465.4 | Standard polar | 33892256 | | L-Threonine,3TMS,isomer #2 | C[C@@H](O[Si](C)(C)C)[C@@H](C(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 1535.8 | Semi standard non polar | 33892256 | | L-Threonine,3TMS,isomer #2 | C[C@@H](O[Si](C)(C)C)[C@@H](C(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 1418.8 | Standard non polar | 33892256 | | L-Threonine,3TMS,isomer #2 | C[C@@H](O[Si](C)(C)C)[C@@H](C(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 1539.1 | Standard polar | 33892256 | | L-Threonine,3TMS,isomer #3 | C[C@@H](O)[C@@H](C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1489.9 | Semi standard non polar | 33892256 | | L-Threonine,3TMS,isomer #3 | C[C@@H](O)[C@@H](C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1417.2 | Standard non polar | 33892256 | | L-Threonine,3TMS,isomer #3 | C[C@@H](O)[C@@H](C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1578.1 | Standard polar | 33892256 | | L-Threonine,4TMS,isomer #1 | C[C@@H](O[Si](C)(C)C)[C@@H](C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1610.6 | Semi standard non polar | 33892256 | | L-Threonine,4TMS,isomer #1 | C[C@@H](O[Si](C)(C)C)[C@@H](C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1526.2 | Standard non polar | 33892256 | | L-Threonine,4TMS,isomer #1 | C[C@@H](O[Si](C)(C)C)[C@@H](C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1435.9 | Standard polar | 33892256 | | L-Threonine,1TBDMS,isomer #1 | C[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](N)C(=O)O | 1472.7 | Semi standard non polar | 33892256 | | L-Threonine,1TBDMS,isomer #2 | C[C@@H](O)[C@H](N)C(=O)O[Si](C)(C)C(C)(C)C | 1388.8 | Semi standard non polar | 33892256 | | L-Threonine,1TBDMS,isomer #3 | C[C@@H](O)[C@H](N[Si](C)(C)C(C)(C)C)C(=O)O | 1524.1 | Semi standard non polar | 33892256 | | L-Threonine,2TBDMS,isomer #1 | C[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](N)C(=O)O[Si](C)(C)C(C)(C)C | 1733.6 | Semi standard non polar | 33892256 | | L-Threonine,2TBDMS,isomer #2 | C[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](N[Si](C)(C)C(C)(C)C)C(=O)O | 1786.0 | Semi standard non polar | 33892256 | | L-Threonine,2TBDMS,isomer #3 | C[C@@H](O)[C@H](N[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 1716.7 | Semi standard non polar | 33892256 | | L-Threonine,2TBDMS,isomer #4 | C[C@@H](O)[C@@H](C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 1898.5 | Semi standard non polar | 33892256 | | L-Threonine,3TBDMS,isomer #1 | C[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](N[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2028.1 | Semi standard non polar | 33892256 | | L-Threonine,3TBDMS,isomer #1 | C[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](N[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2022.7 | Standard non polar | 33892256 | | L-Threonine,3TBDMS,isomer #1 | C[C@@H](O[Si](C)(C)C(C)(C)C)[C@H](N[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 1904.4 | Standard polar | 33892256 | | L-Threonine,3TBDMS,isomer #2 | C[C@@H](O[Si](C)(C)C(C)(C)C)[C@@H](C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2173.4 | Semi standard non polar | 33892256 | | L-Threonine,3TBDMS,isomer #2 | C[C@@H](O[Si](C)(C)C(C)(C)C)[C@@H](C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2086.3 | Standard non polar | 33892256 | | L-Threonine,3TBDMS,isomer #2 | C[C@@H](O[Si](C)(C)C(C)(C)C)[C@@H](C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 1916.1 | Standard polar | 33892256 | | L-Threonine,3TBDMS,isomer #3 | C[C@@H](O)[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2113.1 | Semi standard non polar | 33892256 | | L-Threonine,3TBDMS,isomer #3 | C[C@@H](O)[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2081.0 | Standard non polar | 33892256 | | L-Threonine,3TBDMS,isomer #3 | C[C@@H](O)[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 1946.9 | Standard polar | 33892256 | | L-Threonine,4TBDMS,isomer #1 | C[C@@H](O[Si](C)(C)C(C)(C)C)[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2414.5 | Semi standard non polar | 33892256 | | L-Threonine,4TBDMS,isomer #1 | C[C@@H](O[Si](C)(C)C(C)(C)C)[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2327.4 | Standard non polar | 33892256 | | L-Threonine,4TBDMS,isomer #1 | C[C@@H](O[Si](C)(C)C(C)(C)C)[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 1973.3 | Standard polar | 33892256 |
|
|---|
| Spectra |
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental GC-MS | GC-MS Spectrum - L-Threonine GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) (3 TMS) | splash10-0gb9-0930000000-045341234639d940688b | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | | Experimental GC-MS | GC-MS Spectrum - L-Threonine GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) (Non-derivatized) | splash10-0gb9-0930000000-08f448150a2533471625 | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | | Experimental GC-MS | GC-MS Spectrum - L-Threonine GC-MS (2 TMS) | splash10-0159-1910000000-98a39d63665a1a1855dd | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | | Experimental GC-MS | GC-MS Spectrum - L-Threonine GC-MS (3 TMS) | splash10-014i-1960000000-82e1bd8ff2e302e6b51b | 2014-06-16 | HMDB team, MONA, MassBank | View Spectrum | | Experimental GC-MS | GC-MS Spectrum - L-Threonine EI-B (Non-derivatized) | splash10-0159-0910000000-d36a7a07f0444e55e38f | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | | Experimental GC-MS | GC-MS Spectrum - L-Threonine EI-B (Non-derivatized) | splash10-014i-0980000000-ebba7965f95f804648ab | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | | Experimental GC-MS | GC-MS Spectrum - L-Threonine GC-EI-TOF (Non-derivatized) | splash10-0gb9-0930000000-045341234639d940688b | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | | Experimental GC-MS | GC-MS Spectrum - L-Threonine GC-EI-TOF (Non-derivatized) | splash10-0gb9-0930000000-08f448150a2533471625 | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | | Experimental GC-MS | GC-MS Spectrum - L-Threonine GC-EI-QQ (Non-derivatized) | splash10-0ffa-3921000000-05359581d7eb97866c8f | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | | Experimental GC-MS | GC-MS Spectrum - L-Threonine GC-MS (Non-derivatized) | splash10-0159-1910000000-98a39d63665a1a1855dd | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | | Experimental GC-MS | GC-MS Spectrum - L-Threonine GC-MS (Non-derivatized) | splash10-014i-1960000000-82e1bd8ff2e302e6b51b | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - L-Threonine GC-MS (Non-derivatized) - 70eV, Positive | splash10-00dl-9000000000-a05d200d324c3242c239 | 2016-09-22 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - L-Threonine GC-MS (2 TMS) - 70eV, Positive | splash10-0fdk-8930000000-c4701f28963821b700b3 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - L-Threonine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - L-Threonine GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - L-Threonine GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - L-Threonine GC-MS (TMS_1_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - L-Threonine GC-MS (TMS_2_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - L-Threonine GC-MS (TMS_2_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - L-Threonine GC-MS (TMS_2_4) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - L-Threonine GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - L-Threonine GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - L-Threonine GC-MS (TBDMS_1_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - L-Threonine GC-MS (TBDMS_2_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - L-Threonine GC-MS (TBDMS_2_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - L-Threonine Quattro_QQQ 10V, Positive-QTOF (Annotated) | splash10-00di-9300000000-85dce837b0f965e73c8a | 2012-07-24 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - L-Threonine Quattro_QQQ 25V, Positive-QTOF (Annotated) | splash10-0a4i-9000000000-221510fd551c0b52c362 | 2012-07-24 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - L-Threonine Quattro_QQQ 40V, Positive-QTOF (Annotated) | splash10-0a4i-9100000000-6ee11649899572cd4867 | 2012-07-24 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - L-Threonine LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Positive-QTOF | splash10-00di-0900000000-fde7ef1951fddff4b817 | 2012-08-31 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - L-Threonine LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Positive-QTOF | splash10-0uk9-8900000000-2d7e5609618437e59272 | 2012-08-31 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - L-Threonine LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Positive-QTOF | splash10-000i-9000000000-4b43567f4a446aed0828 | 2012-08-31 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - L-Threonine LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Positive-QTOF | splash10-014i-4900000000-45382d9abd25be948e5b | 2012-08-31 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - L-Threonine LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Positive-QTOF | splash10-00di-0900000000-071b61d3ea723715c1c1 | 2012-08-31 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - L-Threonine LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Positive-QTOF | splash10-0a59-9000000000-c8320d0556dbe72049ca | 2012-08-31 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - L-Threonine LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Positive-QTOF | splash10-0uk9-8900000000-9945ecd06408cb733177 | 2012-08-31 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - L-Threonine LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Positive-QTOF | splash10-0ufr-8900000000-c9804e2bfc51ec0e8593 | 2012-08-31 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - L-Threonine LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Negative-QTOF | splash10-02t9-0692200000-f96dba3c74726ede32de | 2012-08-31 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - L-Threonine LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Negative-QTOF | splash10-00di-9000000000-94eeca12e76e23c1695e | 2012-08-31 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - L-Threonine LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Negative-QTOF | splash10-014i-0930000000-efff9b10ae39f6ce6095 | 2012-08-31 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - L-Threonine LC-ESI-ITFT (LTQ Orbitrap XL, Thermo Scientfic) , Negative-QTOF | splash10-014i-0190000000-74ab3cba7b57b1b1b681 | 2012-08-31 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - L-Threonine LC-ESI-QQ (API3000, Applied Biosystems) 10V, Negative-QTOF | splash10-014i-1900000000-d9348197a5df9756d30c | 2012-08-31 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - L-Threonine LC-ESI-QQ (API3000, Applied Biosystems) 20V, Negative-QTOF | splash10-00di-9100000000-9008bb1dfd2806e9f87d | 2012-08-31 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - L-Threonine LC-ESI-QQ (API3000, Applied Biosystems) 30V, Negative-QTOF | splash10-00di-9000000000-47fd01696817c86aecc5 | 2012-08-31 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - L-Threonine LC-ESI-QQ (API3000, Applied Biosystems) 40V, Negative-QTOF | splash10-00di-9000000000-ba9cd5b3e37ded5d3764 | 2012-08-31 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - L-Threonine LC-ESI-QQ (API3000, Applied Biosystems) 10V, Positive-QTOF | splash10-00di-1900000000-3fa8bd5efd825e5ac3fa | 2012-08-31 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - L-Threonine LC-ESI-QQ (API3000, Applied Biosystems) 20V, Positive-QTOF | splash10-0kn9-9200000000-063cffd047551fca9ee6 | 2012-08-31 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - L-Threonine LC-ESI-QQ (API3000, Applied Biosystems) 30V, Positive-QTOF | splash10-0a4i-9000000000-8b82bffd35f30875a7c0 | 2012-08-31 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - L-Threonine LC-ESI-QQ (API3000, Applied Biosystems) 40V, Positive-QTOF | splash10-0a4i-9000000000-1748dd9a759c98e1c5ee | 2012-08-31 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - L-Threonine LC-ESI-QQ (API3000, Applied Biosystems) 50V, Positive-QTOF | splash10-0a4i-9000000000-e9069de219196460cc61 | 2012-08-31 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - L-Threonine 10V, Positive-QTOF | splash10-0uk9-6900000000-d30fcc60bda11aeb88b4 | 2016-09-12 | Wishart Lab | View Spectrum |
NMR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Experimental 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, experimental) | 2012-12-04 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-29 | Wishart Lab | View Spectrum | | Experimental 1D NMR | 13C NMR Spectrum (1D, 400 MHz, H2O, experimental) | 2021-10-10 | Wishart Lab | View Spectrum | | Experimental 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 400 MHz, H2O, experimental) | 2012-12-05 | Wishart Lab | View Spectrum |
IR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M-H]-) | 2023-02-03 | FELIX lab | View Spectrum | | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+H]+) | 2023-02-03 | FELIX lab | View Spectrum | | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+Na]+) | 2023-02-03 | FELIX lab | View Spectrum |
|
|---|
| Biological Properties |
|---|
| Cellular Locations | |
|---|
| Biospecimen Locations | - Blood
- Breast Milk
- Cerebrospinal Fluid (CSF)
- Feces
- Saliva
- Sweat
- Urine
|
|---|
| Tissue Locations | - All Tissues
- Placenta
- Prostate
|
|---|
| Pathways | |
|---|
| Normal Concentrations |
|---|
| |
| Blood | Detected and Quantified | 140.0 (107.0-173.0) uM | Adult (>18 years old) | Both | Normal | | details | | Blood | Detected and Quantified | 215.0 +/- 60.0 uM | Newborn (0-30 days old) | Not Specified | Normal | | details | | Blood | Detected and Quantified | 140.0 +/- 28.0 uM | Children (1-13 years old) | Male | Normal | | details | | Blood | Detected and Quantified | 146.0 +/- 22.0 uM | Adult (>18 years old) | Male | Normal | | details | | Blood | Detected and Quantified | 154.0 +/- 40.0 uM | Adult (>18 years old) | Female | Normal | | details | | Blood | Detected and Quantified | 260.0 +/- 10.0 uM | Adult (>18 years old) | Both | Normal | | details | | Blood | Detected and Quantified | 127.7 +/- 41 uM | Adult (>18 years old) | Both | Normal | | details | | Blood | Detected and Quantified | 102.3 +/- 24.6 uM | Adult (>18 years old) | Both | Normal | | details | | Blood | Detected and Quantified | 43-150 uM | Newborn (0-30 days old) | Both | Normal | | details | | Blood | Detected and Quantified | 47-150 uM | Infant (1 - 3 months old) | Both | Normal | | details | | Blood | Detected and Quantified | 40-300 uM | Children (3 months - 6 years old) | Both | Normal | | details | | Blood | Detected and Quantified | 74-250 uM | Children (6 - 18 years old) | Both | Normal | | details | | Blood | Detected and Quantified | 126 +/- 7.44 uM | Adult (>18 years old) | Both | Normal | | details | | Blood | Detected and Quantified | 127.9 +/- 28.2 uM | Adult (>18 years old) | Both | Normal | | details | | Blood | Detected and Quantified | 80.00-220.0 uM | Adult (>18 years old) | Both | Normal | | details | | Blood | Detected and Quantified | 90-329 uM | Infant (0-1 year old) | Not Specified | Normal | | details | | Blood | Detected and Quantified | 89.7(72.1-105.4) uM | Children (1-13 uears old) | Both | Normal | | details | | Blood | Detected and Quantified | <10 uM | Newborn (0-30 days old) | Not Specified | Normal | | details | | Blood | Detected and Quantified | 70-220 uM | Newborn (0-30 days old) | Not Specified | Normal | | details | | Blood | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | | Blood | Detected and Quantified | 131.33 ± 22.18 uM | Adult (>18 years old) | Both | Normal | | details | | Blood | Detected and Quantified | 192.8 ± 59.01 uM | Adult (>18 years old) | Both | Normal | | details | | Blood | Detected and Quantified | 145.65 ± 99.13 uM | Adult (>18 years old) | Both | Normal | | details | | Blood | Detected and Quantified | 150.13 ± 50.98 uM | Adult (>18 years old) | Both | Normal | | details | | Blood | Detected and Quantified | 168.6 ± 76.72 uM | Adult (>18 years old) | Both | Normal | | details | | Blood | Detected and Quantified | 121.83 ± 50.52 uM | Adult (>18 years old) | Both | Normal | | details | | Blood | Detected and Quantified | 163.47 ± 67.54 uM | Adult (>18 years old) | Both | Normal | | details | | Blood | Detected and Quantified | 153.33 ± 51.06 uM | Adult (>18 years old) | Both | Normal | | details | | Blood | Detected and Quantified | 124.54 ± 38.33 uM | Adult (>18 years old) | Both | Normal | | details | | Breast Milk | Detected and Quantified | 96.5 +/- 31.4 uM | Adult (>18 years old) | Female | Normal | | details | | Cerebrospinal Fluid (CSF) | Detected and Quantified | 27.7 +/- 4.7 umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | | Cerebrospinal Fluid (CSF) | Detected and Quantified | 32.0 (4.00-60.0) uM | Adult (>18 years old) | Both | Normal | | details | | Cerebrospinal Fluid (CSF) | Detected and Quantified | 45.9 +/- 12.3 uM | Adult (>18 years old) | Not Specified | Normal | | details | | Cerebrospinal Fluid (CSF) | Detected and Quantified | 37.4 +/- 7.6 uM | Adult (>18 years old) | Not Specified | Normal | | details | | Cerebrospinal Fluid (CSF) | Detected and Quantified | 34.7 +/- 6.2 uM | Adult (>18 years old) | Not Specified | Normal | | details | | Cerebrospinal Fluid (CSF) | Detected and Quantified | 30 +/- 12 uM | Adult (>18 years old) | Both | Normal | | details | | Cerebrospinal Fluid (CSF) | Detected and Quantified | 10.35 +/- 0.88 uM | Adult (>18 years old) | Both | Normal | | details | | Cerebrospinal Fluid (CSF) | Detected and Quantified | 26.5 +/- 4.2 uM | Adult (>18 years old) | Not Specified | Normal | | details | | Cerebrospinal Fluid (CSF) | Detected and Quantified | 8-46 uM | Children (0 - 10 years old) | Both | Normal | | details | | Cerebrospinal Fluid (CSF) | Detected and Quantified | 6.5-56 uM | Adolescent (>11 years old) | Both | Normal | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | | Feces | Detected but not Quantified | Not Quantified | Not Specified | Not Specified | Normal | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | | Feces | Detected but not Quantified | Not Quantified | Infant (0-1 year old) | Both | Normal | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | | Feces | Detected and Quantified | 4309.409 (2770.334-5848.483) nmol/g wet feces | Infant (0-1 year old) | Not Specified | Normal | | details | | Feces | Detected and Quantified | 6212.265 (1063.361-11361.169) nmol/g wet feces | Infant (0-1 year old) | Not Specified | Normal | | details | | Feces | Detected and Quantified | 6771.928 (1846.890-11696.967) nmol/g wet feces | Infant (0-1 year old) | Not Specified | Normal | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Female | Normal | | details | | Feces | Detected but not Quantified | Not Quantified | Not Specified | Both | Normal | | details | | Feces | Detected but not Quantified | Not Quantified | Children (1-13 years old) | Both | Normal | | details | | Feces | Detected but not Quantified | Not Quantified | Children (6 - 18 years old) | Both | Normal | | details | | Feces | Detected but not Quantified | Not Quantified | Children (6 - 18 years old) | Not Specified | Normal | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Female | Normal | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Not Specified | Normal | | details | | Feces | Detected and Quantified | 320 +/- 220 nmol/g wet feces | Adult (>18 years old) | Both | Normal | | details | | Feces | Detected and Quantified | 40 +/- 30 nmol/g wet feces | Adult (>18 years old) | Both | Normal | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | | Saliva | Detected and Quantified | >10 uM | Adult (>18 years old) | Both | Normal | | details | | Saliva | Detected and Quantified | 26.75 +/- 28.12 uM | Adult (>18 years old) | Both | Normal | | details | | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | | Saliva | Detected and Quantified | <0.25 uM | Adult (>18 years old) | Male | Normal | | details | | Saliva | Detected and Quantified | <0.25 uM | Adult (>18 years old) | Male | Normal | | details | | Saliva | Detected and Quantified | 3.7 +/- 3.6 uM | Adult (>18 years old) | Male | Normal | | details | | Saliva | Detected and Quantified | 3.7 +/- 0.45 uM | Adult (>18 years old) | Male | Normal | | details | | Saliva | Detected and Quantified | 6.27 +/- 3.07 uM | Adult (>18 years old) | Female | Normal | | details | | Saliva | Detected and Quantified | 3.50 +/- 4.89 uM | Adult (>18 years old) | Female | Normal | | details | | Saliva | Detected and Quantified | 3.96 +/- 2.50 uM | Adult (>18 years old) | Female | Normal | | details | | Saliva | Detected and Quantified | 7.78 +/- 13.5 uM | Adult (>18 years old) | Female | Normal | | details | | Saliva | Detected and Quantified | 7.98 +/- 7.32 uM | Adult (>18 years old) | Both | Normal | | details | | Sweat | Detected and Quantified | < 10 uM | Adult (60 years old) | Male | Normal | | details | | Sweat | Detected and Quantified | < 10 uM | Adult (40 years old) | Male | Normal | | details | | Urine | Detected and Quantified | 36.20 +/- 25.38 umol/mmol creatinine | Infant (0-1 year old) | Both | Normal | | details | | Urine | Detected and Quantified | 12.7 (4.934-20.4) umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | | Urine | Detected and Quantified | 1.0 (0.16-2.4) umol/mmol creatinine | Newborn (0-30 days old) | Both | Normal | - Geigy Scientific ...
- West Cadwell, N.J...
- Basel, Switzerlan...
| details | | Urine | Detected and Quantified | 4.9 +/- 2.5 umol/mmol creatinine | Children (1-13 years old) | Female | Normal | - Geigy Scientific ...
- West Cadwell, N.J...
- Basel, Switzerlan...
| details | | Urine | Detected and Quantified | 18.0 +/- 9.6 umol/mmol creatinine | Adult (>18 years old) | Male | Normal | - Geigy Scientific ...
- West Cadwell, N.J...
- Basel, Switzerlan...
| details | | Urine | Detected and Quantified | 16.0 +/- 9.0 umol/mmol creatinine | Adult (>18 years old) | Female | Normal | - Geigy Scientific ...
- West Cadwell, N.J...
- Basel, Switzerlan...
| details | | Urine | Detected and Quantified | 10.3 umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | | Urine | Detected and Quantified | 8.40-100.79 umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | | Urine | Detected and Quantified | 5.17-24.59 umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | | Urine | Detected and Quantified | 13.4 umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | | Urine | Detected and Quantified | 14.6 (6.6-29.3) umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | | Urine | Detected and Quantified | 13.3 (6.4-25.2) umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | | Urine | Detected and Quantified | 34.7611 +/- 13.8297 umol/mmol creatinine | Children (1 - 13 years old) | Not Specified | Normal | | details | | Urine | Detected and Quantified | 25.712 +/- 16.04 umol/mmol creatinine | Children (1 - 13 years old) | Not Specified | Normal | | details | | Urine | Detected and Quantified | 20.24 - 126.97 umol/mmol creatinine | Newborn (0-30 days old) | Both | Normal | | details | | Urine | Detected and Quantified | 17.41 - 85.36 umol/mmol creatinine | Infant (1 - 6 months old) | Both | Normal | | details | | Urine | Detected and Quantified | 14.81 - 52.80 umol/mmol creatinine | Infant (6 months - <1 year old) | Both | Normal | | details | | Urine | Detected and Quantified | 15.72 - 58.23 umol/mmol creatinine | Children (1 - 2 years old) | Both | Normal | | details | | Urine | Detected and Quantified | 11.08 - 45.56 umol/mmol creatinine | Children (2 - 4 years old) | Both | Normal | | details | | Urine | Detected and Quantified | 9.38 - 34.60 umol/mmol creatinine | Children (4 - 13 years old) | Both | Normal | | details | | Urine | Detected and Quantified | 7.01 - 29.06 umol/mmol creatinine | Adolescent (13 - 21 years old) | Both | Normal | | details | | Urine | Detected and Quantified | 8.48 - 28.38 umol/mmol creatinine | Adult (>21 years old) | Both | Normal | | details | | Urine | Detected and Quantified | 6.8-14 umol/mmol creatinine | Adult (>18 years old) | Female | Normal | | details | | Urine | Detected and Quantified | 11-20 umol/mmol creatinine | Adult (>18 years old) | Male | Normal | | details | | Urine | Detected and Quantified | 14.0194-126.401 umol/mmol creatinine | Infant (0-1 year old) | Not Specified | Normal | | details | | Urine | Detected and Quantified | 2.8 +/- 1.3 umol/mmol creatinine | Newborn (0-30 days old) | Both | Normal | | details | | Urine | Detected and Quantified | 2.9 +/- 1.2 umol/mmol creatinine | Infant (6 months - <1 year old) | Both | Normal | | details | | Urine | Detected and Quantified | 3.1 +/- 1.1 umol/mmol creatinine | Infant (1 - 6 months old) | Both | Normal | | details | | Urine | Detected and Quantified | 316.57 +/- 260.04 umol/mmol creatinine | Newborn (0-30 days old) | Both | Normal | | details | | Urine | Detected and Quantified | 542.69 +/- 350.49 umol/mmol creatinine | Newborn (0-30 days old) | Both | Normal | | details | | Urine | Detected and Quantified | 814.03 +/- 587.91 umol/mmol creatinine | Newborn (0-30 days old) | Both | Normal | | details | | Urine | Detected and Quantified | 2.58-81.52 umol/mmol creatinine | Newborn (0-30 days old) | Female | Normal | | details | | Urine | Detected and Quantified | 0.58-73.49 umol/mmol creatinine | Newborn (0-30 days old) | Male | Normal | | details | | Urine | Detected and Quantified | 23.47 +/- 23.89 umol/mmol creatinine | Newborn (0-30 days old) | Male | Normal | | details | | Urine | Detected and Quantified | 24.64 +/- 21.56 umol/mmol creatinine | Newborn (0-30 days old) | Female | Normal | | details | | Urine | Detected and Quantified | 25.02 +/- 18.68 umol/mmol creatinine | Children (0-2 years old) | Female | Normal | | details | | Urine | Detected and Quantified | 26.48 +/- 21.33 umol/mmol creatinine | Children (0-2 years old) | Male | Normal | | details | | Urine | Detected and Quantified | 15-136 umol/mmol creatinine | Infant (0-1 year old) | Both | Normal | | details | | Urine | Detected and Quantified | 9.24-96.17 umol/mmol creatinine | Newborn (0-30 days old) | Both | Normal | | details | | Urine | Detected and Quantified | 25.44(15.16-69.43) umol/mmol creatinine | Newborn (0-30 days old) | Female | Normal | | details | | Urine | Detected and Quantified | 30.69(9.10-99.45) umol/mmol creatinine | Newborn (0-30 days old) | Male | Normal | | details | | Urine | Detected and Quantified | 2.83-137.64 umol/mmol creatinine | Infant (0-1 year old) | Not Specified | Normal | | details | | Urine | Detected and Quantified | 6.22-86.31 umol/mmol creatinine | Children (1-13 years old) | Not Specified | Normal | | details | | Urine | Detected and Quantified | 3.39-62.67 umol/mmol creatinine | Children (1-13 years old) | Not Specified | Normal | | details | | Urine | Detected and Quantified | 2.83-51.58 umol/mmol creatinine | Children (1-13 years old) | Not Specified | Normal | | details | | Urine | Detected and Quantified | 4.19-47.28 umol/mmol creatinine | Adolescent (13-18 years old) | Not Specified | Normal | | details | | Urine | Detected and Quantified | 3.51-31.45 umol/mmol creatinine | Adult (>18 years old) | Not Specified | Normal | | details | | Urine | Detected and Quantified | 56.31 (24.51-119.66) umol/mmol creatinine | Newborn (0-30 days old) | Both | Normal | | details |
|
|---|
| Abnormal Concentrations |
|---|
| |
| Blood | Detected and Quantified | 118.0 +/- 3.8 uM | Adult (>18 years old) | Both | Epilepsy | | details | | Blood | Detected and Quantified | 114.0 +/- 9.2 uM | Adult (>18 years old) | Both | Epilepsy | | details | | Blood | Detected and Quantified | 127.1 (29.0) uM | Adult (>18 years old) | Female | Early preeclampsia | | details | | Blood | Detected and Quantified | 111 +/- 10.3 uM | Adult (>18 years old) | Both | Schizophrenia | | details | | Blood | Detected and Quantified | 145.9 (60.3) uM | Adult (>18 years old) | Female | Pregnancy | | details | | Blood | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details | | Blood | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details | | Blood | Detected and Quantified | 157.2 (60.2) uM | Adult (>18 years old) | Female | Late-onset preeclampsia | | details | | Blood | Detected and Quantified | 166.2 (62.5) uM | Adult (>18 years old) | Female | Pregnancy | | details | | Blood | Detected and Quantified | 123.3 (31.8) uM | Adult (>18 years old) | Female | Down syndrome pregnancy | | details | | Blood | Detected and Quantified | 119.3 (45.2) uM | Adult (>18 years old) | Female | Pregnancy | | details | | Blood | Detected and Quantified | 104.34 +/- 48.09 uM | Adult (>18 years old) | Female | Pregnancy with fetuses with trisomy 18 | | details | | Blood | Detected and Quantified | 108.80 +/- 42.53 uM | Adult (>18 years old) | Female | Pregnancy | | details | | Blood | Detected and Quantified | 112.57 (25.66) uM | Adult (>18 years old) | Female | Pregnancy with fetus having congenital heart defect | | details | | Blood | Detected and Quantified | 107.31 (26.21) uM | Adult (>18 years old) | Female | Pregnancy | | details | | Blood | Detected and Quantified | 313 uM | Infant (0-1 year old) | Male | Fumaric aciduria | | details | | Blood | Detected and Quantified | 89.1(69.6-118.1) uM | Children (1-13 uears old) | Both | Environmental enteric dysfunction | | details | | Blood | Detected and Quantified | 73.8 +/- 29.5 uM | Children (1-13 years old) | Both | Obesity | | details | | Blood | Detected and Quantified | 84.5 +/- 28.8 uM | Children (1-13 years old) | Both | Obesity | | details | | Blood | Detected and Quantified | 414-681 uM | Newborn (0-30 days old) | Both | Citrullinemia type II, neonatal-onset | | details | | Blood | Detected and Quantified | 53-542 uM | Newborn (0-30 days old) | Both | Pyridoxamine 5-prime-phosphate oxidase deficiency | | details | | Blood | Detected and Quantified | 83.4 +/- 47.8 uM | Adult (>18 years old) | Both | Heart Transplant | | details | | Blood | Detected and Quantified | 133.92(29.45) uM | Adult (>18 years old) | Both | Heart failure with preserved ejection fraction | | details | | Blood | Detected and Quantified | 227.0 +/- 10.0 uM | Adult (>18 years old) | Both | Heart failure | | details | | Cerebrospinal Fluid (CSF) | Detected and Quantified | 9.68 +/- 2.22 uM | Adult (>18 years old) | Both | Schizophrenia | | details | | Cerebrospinal Fluid (CSF) | Detected and Quantified | 41.0 +/- 15.9 uM | Children (1-13 years old) | Not Specified | Leukemia | | details | | Cerebrospinal Fluid (CSF) | Detected and Quantified | 30.2 +/- 9.8 uM | Children (1-13 years old) | Not Specified | Leukemia | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Female | Myalgic encephalomyelitis/chronic fatigue syndrome | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Female | rheumatoid arthritis | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Female | ankylosing spondylitis | | details | | Feces | Detected but not Quantified | Not Quantified | Children (6 - 18 years old) | Both | Crohns disease | | details | | Feces | Detected but not Quantified | Not Quantified | Children (6 - 18 years old) | Not Specified | Unclassified IBD | | details | | Feces | Detected but not Quantified | Not Quantified | Children (6 - 18 years old) | Not Specified | Ulcerative colitis | | details | | Feces | Detected but not Quantified | Not Quantified | Children (6 - 18 years old) | Both | Ulcerative colitis | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal Cancer | | details | | Feces | Detected but not Quantified | Not Quantified | Children (1-13 years old) | Both | Autism | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Crohn's disease | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details | | Feces | Detected but not Quantified | Not Quantified | Children (6 - 18 years old) | Not Specified | Crohns disease | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Ulcerative colitis | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Irritable bowel syndrome | | details | | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Oral squamous cell carcinoma (OSCC) | | details | | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Periodontal Probing Depth | | details | | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Not Specified | Periodontal diseases | | details | | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Not Specified | Pancreatic cancer | | details | | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Female | Breast cancer | | details | | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Oral cancer | | details | | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Attachment loss | | details | | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Missing teeth | | details | | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Oral leukoplakia (OLK) | | details | | Saliva | Detected and Quantified | 3.65 +/- 0.97 uM | Adult (>18 years old) | Male | Alzheimer's disease | | details | | Saliva | Detected and Quantified | 4.36 +/- 1.21 uM | Adult (>18 years old) | Male | Frontotemporal lobe dementia | | details | | Saliva | Detected and Quantified | 5.83 +/- 3.11 uM | Adult (>18 years old) | Both | Lewy body disease | | details | | Urine | Detected and Quantified | 226.200-1060 umol/mmol creatinine | Infant (0-1 year old) | Not Specified | Fumaric aciduria | | details | | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Autosomal dominant polycystic kidney disease (ADPKD) | | details | | Urine | Detected and Quantified | 0.03 +/- 0.003 umol/mmol creatinine | Adult (>18 years old) | Both | Alzheimer's disease | | details | | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Bladder cancer | | details | | Urine | Detected and Quantified | 29.5912 +/- 12.5053 umol/mmol creatinine | Children (1 - 13 years old) | Not Specified | Eosinophilic esophagitis | | details | | Urine | Detected and Quantified | 23.4612 +/- 14.2639 umol/mmol creatinine | Children (1 - 13 years old) | Not Specified | Gastroesophageal reflux disease | | details | | Urine | Detected and Quantified | 29.908 +/- 30.918 umol/mmol creatinine | Children (1 - 13 years old) | Not Specified | Eosinophilic esophagitis | | details |
|
|---|
| Associated Disorders and Diseases |
|---|
| Disease References | | Fumarase deficiency |
|---|
- Allegri G, Fernandes MJ, Scalco FB, Correia P, Simoni RE, Llerena JC Jr, de Oliveira ML: Fumaric aciduria: an overview and the first Brazilian case report. J Inherit Metab Dis. 2010 Aug;33(4):411-9. doi: 10.1007/s10545-010-9134-2. Epub 2010 Jun 15. [PubMed:20549362 ]
| | Pregnancy |
|---|
- Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomics and first-trimester prediction of early-onset preeclampsia. J Matern Fetal Neonatal Med. 2012 Oct;25(10):1840-7. doi: 10.3109/14767058.2012.680254. Epub 2012 Apr 28. [PubMed:22494326 ]
- Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: First-trimester metabolomic detection of late-onset preeclampsia. Am J Obstet Gynecol. 2013 Jan;208(1):58.e1-7. doi: 10.1016/j.ajog.2012.11.003. Epub 2012 Nov 13. [PubMed:23159745 ]
- Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomic analysis for first-trimester Down syndrome prediction. Am J Obstet Gynecol. 2013 May;208(5):371.e1-8. doi: 10.1016/j.ajog.2012.12.035. Epub 2013 Jan 8. [PubMed:23313728 ]
- Bahado-Singh RO, Akolekar R, Chelliah A, Mandal R, Dong E, Kruger M, Wishart DS, Nicolaides K: Metabolomic analysis for first-trimester trisomy 18 detection. Am J Obstet Gynecol. 2013 Jul;209(1):65.e1-9. doi: 10.1016/j.ajog.2013.03.028. Epub 2013 Mar 25. [PubMed:23535240 ]
- Bahado-Singh RO, Ertl R, Mandal R, Bjorndahl TC, Syngelaki A, Han B, Dong E, Liu PB, Alpay-Savasan Z, Wishart DS, Nicolaides KH: Metabolomic prediction of fetal congenital heart defect in the first trimester. Am J Obstet Gynecol. 2014 Sep;211(3):240.e1-240.e14. doi: 10.1016/j.ajog.2014.03.056. Epub 2014 Apr 1. [PubMed:24704061 ]
| | Early preeclampsia |
|---|
- Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: Metabolomics and first-trimester prediction of early-onset preeclampsia. J Matern Fetal Neonatal Med. 2012 Oct;25(10):1840-7. doi: 10.3109/14767058.2012.680254. Epub 2012 Apr 28. [PubMed:22494326 ]
| | Late-onset preeclampsia |
|---|
- Bahado-Singh RO, Akolekar R, Mandal R, Dong E, Xia J, Kruger M, Wishart DS, Nicolaides K: First-trimester metabolomic detection of late-onset preeclampsia. Am J Obstet Gynecol. 2013 Jan;208(1):58.e1-7. doi: 10.1016/j.ajog.2012.11.003. Epub 2012 Nov 13. [PubMed:23159745 ]
| | Obesity |
|---|
- Simone Wahl, Christina Holzapfel, Zhonghao Yu, Michaela Breier, Ivan Kondofersky, Christiane Fuchs, Paula Singmann, Cornelia Prehn, Jerzy Adamski, Harald Grallert, Thomas Illig, Rui Wang-Sattler, Thomas Reinehr (2013). Metabolomics reveals determinants of weight loss during lifestyle intervention in obese children. Metabolomics.
| | Citrullinemia type II, neonatal-onset |
|---|
- Ohura T, Kobayashi K, Tazawa Y, Nishi I, Abukawa D, Sakamoto O, Iinuma K, Saheki T: Neonatal presentation of adult-onset type II citrullinemia. Hum Genet. 2001 Feb;108(2):87-90. [PubMed:11281457 ]
| | Pyridoxamine 5-prime-phosphate oxidase deficiency |
|---|
- Plecko B, Paul K, Paschke E, Stoeckler-Ipsiroglu S, Struys E, Jakobs C, Hartmann H, Luecke T, di Capua M, Korenke C, Hikel C, Reutershahn E, Freilinger M, Baumeister F, Bosch F, Erwa W: Biochemical and molecular characterization of 18 patients with pyridoxine-dependent epilepsy and mutations of the antiquitin (ALDH7A1) gene. Hum Mutat. 2007 Jan;28(1):19-26. [PubMed:17068770 ]
| | Epilepsy |
|---|
- Rainesalo S, Keranen T, Palmio J, Peltola J, Oja SS, Saransaari P: Plasma and cerebrospinal fluid amino acids in epileptic patients. Neurochem Res. 2004 Jan;29(1):319-24. [PubMed:14992292 ]
| | Heart failure |
|---|
- Norrelund H, Wiggers H, Halbirk M, Frystyk J, Flyvbjerg A, Botker HE, Schmitz O, Jorgensen JO, Christiansen JS, Moller N: Abnormalities of whole body protein turnover, muscle metabolism and levels of metabolic hormones in patients with chronic heart failure. J Intern Med. 2006 Jul;260(1):11-21. [PubMed:16789974 ]
| | Schizophrenia |
|---|
- Do KQ, Lauer CJ, Schreiber W, Zollinger M, Gutteck-Amsler U, Cuenod M, Holsboer F: gamma-Glutamylglutamine and taurine concentrations are decreased in the cerebrospinal fluid of drug-naive patients with schizophrenic disorders. J Neurochem. 1995 Dec;65(6):2652-62. [PubMed:7595563 ]
- Fukushima T, Iizuka H, Yokota A, Suzuki T, Ohno C, Kono Y, Nishikiori M, Seki A, Ichiba H, Watanabe Y, Hongo S, Utsunomiya M, Nakatani M, Sadamoto K, Yoshio T: Quantitative analyses of schizophrenia-associated metabolites in serum: serum D-lactate levels are negatively correlated with gamma-glutamylcysteine in medicated schizophrenia patients. PLoS One. 2014 Jul 8;9(7):e101652. doi: 10.1371/journal.pone.0101652. eCollection 2014. [PubMed:25004141 ]
| | Leukemia |
|---|
- Peng CT, Wu KH, Lan SJ, Tsai JJ, Tsai FJ, Tsai CH: Amino acid concentrations in cerebrospinal fluid in children with acute lymphoblastic leukemia undergoing chemotherapy. Eur J Cancer. 2005 May;41(8):1158-63. Epub 2005 Apr 14. [PubMed:15911239 ]
| | Irritable bowel syndrome |
|---|
- Le Gall G, Noor SO, Ridgway K, Scovell L, Jamieson C, Johnson IT, Colquhoun IJ, Kemsley EK, Narbad A: Metabolomics of fecal extracts detects altered metabolic activity of gut microbiota in ulcerative colitis and irritable bowel syndrome. J Proteome Res. 2011 Sep 2;10(9):4208-18. doi: 10.1021/pr2003598. Epub 2011 Aug 8. [PubMed:21761941 ]
| | Ulcerative colitis |
|---|
- Le Gall G, Noor SO, Ridgway K, Scovell L, Jamieson C, Johnson IT, Colquhoun IJ, Kemsley EK, Narbad A: Metabolomics of fecal extracts detects altered metabolic activity of gut microbiota in ulcerative colitis and irritable bowel syndrome. J Proteome Res. 2011 Sep 2;10(9):4208-18. doi: 10.1021/pr2003598. Epub 2011 Aug 8. [PubMed:21761941 ]
- Kolho KL, Pessia A, Jaakkola T, de Vos WM, Velagapudi V: Faecal and Serum Metabolomics in Paediatric Inflammatory Bowel Disease. J Crohns Colitis. 2017 Mar 1;11(3):321-334. doi: 10.1093/ecco-jcc/jjw158. [PubMed:27609529 ]
| | Colorectal cancer |
|---|
- Weir TL, Manter DK, Sheflin AM, Barnett BA, Heuberger AL, Ryan EP: Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults. PLoS One. 2013 Aug 6;8(8):e70803. doi: 10.1371/journal.pone.0070803. Print 2013. [PubMed:23940645 ]
- Ritchie SA, Ahiahonu PW, Jayasinghe D, Heath D, Liu J, Lu Y, Jin W, Kavianpour A, Yamazaki Y, Khan AM, Hossain M, Su-Myat KK, Wood PL, Krenitsky K, Takemasa I, Miyake M, Sekimoto M, Monden M, Matsubara H, Nomura F, Goodenowe DB: Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection. BMC Med. 2010 Feb 15;8:13. doi: 10.1186/1741-7015-8-13. [PubMed:20156336 ]
- Ni Y, Xie G, Jia W: Metabonomics of human colorectal cancer: new approaches for early diagnosis and biomarker discovery. J Proteome Res. 2014 Sep 5;13(9):3857-70. doi: 10.1021/pr500443c. Epub 2014 Aug 14. [PubMed:25105552 ]
- Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP: Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016 Jun 6;4:11. doi: 10.1186/s40170-016-0151-y. eCollection 2016. [PubMed:27275383 ]
- Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016. [PubMed:27015276 ]
- Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18. [PubMed:25037050 ]
| | Crohn's disease |
|---|
- Marchesi JR, Holmes E, Khan F, Kochhar S, Scanlan P, Shanahan F, Wilson ID, Wang Y: Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J Proteome Res. 2007 Feb;6(2):546-51. [PubMed:17269711 ]
- Kolho KL, Pessia A, Jaakkola T, de Vos WM, Velagapudi V: Faecal and Serum Metabolomics in Paediatric Inflammatory Bowel Disease. J Crohns Colitis. 2017 Mar 1;11(3):321-334. doi: 10.1093/ecco-jcc/jjw158. [PubMed:27609529 ]
| | Autism |
|---|
- De Angelis M, Piccolo M, Vannini L, Siragusa S, De Giacomo A, Serrazzanetti DI, Cristofori F, Guerzoni ME, Gobbetti M, Francavilla R: Fecal microbiota and metabolome of children with autism and pervasive developmental disorder not otherwise specified. PLoS One. 2013 Oct 9;8(10):e76993. doi: 10.1371/journal.pone.0076993. eCollection 2013. [PubMed:24130822 ]
| | Rheumatoid arthritis |
|---|
- Tie-juan ShaoZhi-xing HeZhi-jun XieHai-chang LiMei-jiao WangCheng-ping Wen. Characterization of ankylosing spondylitis and rheumatoid arthritis using 1H NMR-based metabolomics of human fecal extracts. Metabolomics. April 2016, 12:70 [Link]
| | Attachment loss |
|---|
- Liebsch C, Pitchika V, Pink C, Samietz S, Kastenmuller G, Artati A, Suhre K, Adamski J, Nauck M, Volzke H, Friedrich N, Kocher T, Holtfreter B, Pietzner M: The Saliva Metabolome in Association to Oral Health Status. J Dent Res. 2019 Jun;98(6):642-651. doi: 10.1177/0022034519842853. Epub 2019 Apr 26. [PubMed:31026179 ]
| | Missing teeth |
|---|
- Liebsch C, Pitchika V, Pink C, Samietz S, Kastenmuller G, Artati A, Suhre K, Adamski J, Nauck M, Volzke H, Friedrich N, Kocher T, Holtfreter B, Pietzner M: The Saliva Metabolome in Association to Oral Health Status. J Dent Res. 2019 Jun;98(6):642-651. doi: 10.1177/0022034519842853. Epub 2019 Apr 26. [PubMed:31026179 ]
| | Periodontal Probing Depth |
|---|
- Liebsch C, Pitchika V, Pink C, Samietz S, Kastenmuller G, Artati A, Suhre K, Adamski J, Nauck M, Volzke H, Friedrich N, Kocher T, Holtfreter B, Pietzner M: The Saliva Metabolome in Association to Oral Health Status. J Dent Res. 2019 Jun;98(6):642-651. doi: 10.1177/0022034519842853. Epub 2019 Apr 26. [PubMed:31026179 ]
| | Lewy body disease |
|---|
- Tsuruoka M, Hara J, Hirayama A, Sugimoto M, Soga T, Shankle WR, Tomita M: Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients. Electrophoresis. 2013 Oct;34(19):2865-72. doi: 10.1002/elps.201300019. Epub 2013 Sep 6. [PubMed:23857558 ]
| | Frontotemporal dementia |
|---|
- Tsuruoka M, Hara J, Hirayama A, Sugimoto M, Soga T, Shankle WR, Tomita M: Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients. Electrophoresis. 2013 Oct;34(19):2865-72. doi: 10.1002/elps.201300019. Epub 2013 Sep 6. [PubMed:23857558 ]
| | Periodontal disease |
|---|
- Sugimoto M, Wong DT, Hirayama A, Soga T, Tomita M: Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles. Metabolomics. 2010 Mar;6(1):78-95. Epub 2009 Sep 10. [PubMed:20300169 ]
| | Pancreatic cancer |
|---|
- Sugimoto M, Wong DT, Hirayama A, Soga T, Tomita M: Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles. Metabolomics. 2010 Mar;6(1):78-95. Epub 2009 Sep 10. [PubMed:20300169 ]
| | Perillyl alcohol administration for cancer treatment |
|---|
- Sugimoto M, Wong DT, Hirayama A, Soga T, Tomita M: Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles. Metabolomics. 2010 Mar;6(1):78-95. Epub 2009 Sep 10. [PubMed:20300169 ]
| | Eosinophilic esophagitis |
|---|
- Slae, M., Huynh, H., Wishart, D.S. (2014). Analysis of 30 normal pediatric urine samples via NMR spectroscopy (unpublished work). NA.
| | Autosomal dominant polycystic kidney disease |
|---|
- Gronwald W, Klein MS, Zeltner R, Schulze BD, Reinhold SW, Deutschmann M, Immervoll AK, Boger CA, Banas B, Eckardt KU, Oefner PJ: Detection of autosomal dominant polycystic kidney disease by NMR spectroscopic fingerprinting of urine. Kidney Int. 2011 Jun;79(11):1244-53. doi: 10.1038/ki.2011.30. Epub 2011 Mar 9. [PubMed:21389975 ]
| | Alzheimer's disease |
|---|
- Fonteh AN, Harrington RJ, Tsai A, Liao P, Harrington MG: Free amino acid and dipeptide changes in the body fluids from Alzheimer's disease subjects. Amino Acids. 2007 Feb;32(2):213-24. Epub 2006 Oct 10. [PubMed:17031479 ]
- Tsuruoka M, Hara J, Hirayama A, Sugimoto M, Soga T, Shankle WR, Tomita M: Capillary electrophoresis-mass spectrometry-based metabolome analysis of serum and saliva from neurodegenerative dementia patients. Electrophoresis. 2013 Oct;34(19):2865-72. doi: 10.1002/elps.201300019. Epub 2013 Sep 6. [PubMed:23857558 ]
|
|
|---|
| Associated OMIM IDs | - 606812 (Fumarase deficiency)
- 601665 (Obesity)
- 605814 (Citrullinemia type II, neonatal-onset)
- 610090 (Pyridoxamine 5-prime-phosphate oxidase deficiency)
- 181500 (Schizophrenia)
- 114500 (Colorectal cancer)
- 266600 (Crohn's disease)
- 209850 (Autism)
- 180300 (Rheumatoid arthritis)
- 260350 (Pancreatic cancer)
- 170650 (Periodontal disease)
- 600274 (Frontotemporal dementia)
- 104300 (Alzheimer's disease)
- 601313 (Autosomal dominant polycystic kidney disease)
- 610247 (Eosinophilic esophagitis)
|
|---|
| External Links |
|---|
| DrugBank ID | DB00156 |
|---|
| Phenol Explorer Compound ID | Not Available |
|---|
| FooDB ID | FDB011999 |
|---|
| KNApSAcK ID | C00001394 |
|---|
| Chemspider ID | 6051 |
|---|
| KEGG Compound ID | C00188 |
|---|
| BioCyc ID | THR |
|---|
| BiGG ID | 34186 |
|---|
| Wikipedia Link | Threonine |
|---|
| METLIN ID | 32 |
|---|
| PubChem Compound | 6288 |
|---|
| PDB ID | Not Available |
|---|
| ChEBI ID | 16857 |
|---|
| Food Biomarker Ontology | Not Available |
|---|
| VMH ID | THR_L |
|---|
| MarkerDB ID | MDB00000081 |
|---|
| Good Scents ID | Not Available |
|---|
| References |
|---|
| Synthesis Reference | Fujita, Chuzo; Nara, Takashi; Samejima, Hirotoshi; Kinoshita, Shukuo. L-Threonine fermentation. I. Microbial conversion of L-homoserine to L-threonine. Nippon Nogei Kagaku Kaishi (1965), 39(6), 2 |
|---|
| Material Safety Data Sheet (MSDS) | Download (PDF) |
|---|
| General References | - Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, Laxman B, Mehra R, Lonigro RJ, Li Y, Nyati MK, Ahsan A, Kalyana-Sundaram S, Han B, Cao X, Byun J, Omenn GS, Ghosh D, Pennathur S, Alexander DC, Berger A, Shuster JR, Wei JT, Varambally S, Beecher C, Chinnaiyan AM: Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature. 2009 Feb 12;457(7231):910-4. doi: 10.1038/nature07762. [PubMed:19212411 ]
- Silwood CJ, Lynch E, Claxson AW, Grootveld MC: 1H and (13)C NMR spectroscopic analysis of human saliva. J Dent Res. 2002 Jun;81(6):422-7. [PubMed:12097436 ]
- Nicholson JK, O'Flynn MP, Sadler PJ, Macleod AF, Juul SM, Sonksen PH: Proton-nuclear-magnetic-resonance studies of serum, plasma and urine from fasting normal and diabetic subjects. Biochem J. 1984 Jan 15;217(2):365-75. [PubMed:6696735 ]
- Wevers RA, Engelke U, Wendel U, de Jong JG, Gabreels FJ, Heerschap A: Standardized method for high-resolution 1H-NMR of cerebrospinal fluid. Clin Chem. 1995 May;41(5):744-51. [PubMed:7729054 ]
- Hagenfeldt L, Bjerkenstedt L, Edman G, Sedvall G, Wiesel FA: Amino acids in plasma and CSF and monoamine metabolites in CSF: interrelationship in healthy subjects. J Neurochem. 1984 Mar;42(3):833-7. [PubMed:6198473 ]
- Peng CT, Wu KH, Lan SJ, Tsai JJ, Tsai FJ, Tsai CH: Amino acid concentrations in cerebrospinal fluid in children with acute lymphoblastic leukemia undergoing chemotherapy. Eur J Cancer. 2005 May;41(8):1158-63. Epub 2005 Apr 14. [PubMed:15911239 ]
- Cynober LA: Plasma amino acid levels with a note on membrane transport: characteristics, regulation, and metabolic significance. Nutrition. 2002 Sep;18(9):761-6. [PubMed:12297216 ]
- Rainesalo S, Keranen T, Palmio J, Peltola J, Oja SS, Saransaari P: Plasma and cerebrospinal fluid amino acids in epileptic patients. Neurochem Res. 2004 Jan;29(1):319-24. [PubMed:14992292 ]
- Vold BS, Keith DE Jr, Slavik M: Urine levels of N-[9-(beta-D-ribofuranosyl)purin-6-ylcarbamoyl]-L-threonine, N6-(delta 2-isopentenyl)adenosine, and 2'-O-methylguanosine as determined by radioimmunoassay for normal subjects and cancer patients. Cancer Res. 1982 Dec;42(12):5265-9. [PubMed:7139629 ]
- Hallgren P, Lundblad A, Svensson S: A new type of carbohydrate-protein linkage in a glycopeptide from normal human urine. J Biol Chem. 1975 Jul 25;250(14):5312-4. [PubMed:1141232 ]
- Wulf G, Finn G, Suizu F, Lu KP: Phosphorylation-specific prolyl isomerization: is there an underlying theme? Nat Cell Biol. 2005 May;7(5):435-41. [PubMed:15867923 ]
- Takeda DY, Parvin JD, Dutta A: Degradation of Cdt1 during S phase is Skp2-independent and is required for efficient progression of mammalian cells through S phase. J Biol Chem. 2005 Jun 17;280(24):23416-23. Epub 2005 Apr 25. [PubMed:15855168 ]
- Nanda N, Bao M, Lin H, Clauser K, Komuves L, Quertermous T, Conley PB, Phillips DR, Hart MJ: Platelet endothelial aggregation receptor 1 (PEAR1), a novel epidermal growth factor repeat-containing transmembrane receptor, participates in platelet contact-induced activation. J Biol Chem. 2005 Jul 1;280(26):24680-9. Epub 2005 Apr 25. [PubMed:15851471 ]
- Boneh A, Korman SH, Sato K, Kanno J, Matsubara Y, Lerer I, Ben-Neriah Z, Kure S: A single nucleotide substitution that abolishes the initiator methionine codon of the GLDC gene is prevalent among patients with glycine encephalopathy in Jerusalem. J Hum Genet. 2005;50(5):230-4. Epub 2005 Apr 29. [PubMed:15864413 ]
- Elzinga M, Maron BJ, Adelstein RS: Human heart and platelet actins are products of different genes. Science. 1976 Jan 9;191(4222):94-5. [PubMed:1246600 ]
- Rodriguez-Soriano J, Vallo A, Perez de Nanclares G, Bilbao JR, Castano L: A founder mutation in the CLCNKB gene causes Bartter syndrome type III in Spain. Pediatr Nephrol. 2005 Jul;20(7):891-6. Epub 2005 May 5. [PubMed:15875219 ]
- Boehm G, Cervantes H, Georgi G, Jelinek J, Sawatzki G, Wermuth B, Colombo JP: Effect of increasing dietary threonine intakes on amino acid metabolism of the central nervous system and peripheral tissues in growing rats. Pediatr Res. 1998 Dec;44(6):900-6. [PubMed:9853925 ]
- Elshenawy S, Pinney SE, Stuart T, Doulias PT, Zura G, Parry S, Elovitz MA, Bennett MJ, Bansal A, Strauss JF 3rd, Ischiropoulos H, Simmons RA: The Metabolomic Signature of the Placenta in Spontaneous Preterm Birth. Int J Mol Sci. 2020 Feb 4;21(3). pii: ijms21031043. doi: 10.3390/ijms21031043. [PubMed:32033212 ]
|
|---|